News

Richard R. Furman, M.D., discusses factors to consider when choosing upfront therapy for patients with chronic lymphocytic leukemia (CLL). Read more

Maria De Sancho, M.D., discusses the increased risk of deep vein thrombosis among cancer patients. Read more

Profile of postdoctoral researcher Ana Patricia Da Silva Gomes, Ph.D. Read more

John P. Leonard, M.D., professor of medicine, discusses some of the exciting advancements taking place in the field of mantle cell lymphoma (MCL). Read more

Gail Roboz, M.D., discusses the challenges clinicians are facing with chimeric antigen receptor (CAR) T-cell therapy in acute lymphoblastic leukemia (ALL). Read more

Clinical trials in patients with follicular lymphoma (FL) mandate that patients undergo bone marrow biopsies (BMBs) at baseline and at subsequent points following treatment in order to monitor response, but the biopsies are unnecessary in most patients, argues Sarah Rutherford, M.D., and colleagues. Read more

Four interdisciplinary teams of physicians and scientists from Weill Cornell Medicine have been announced as recipients of the Sandra and Edward Meyer Cancer Center's inaugural Collaborative Research Initiative pilot project grants. Read more

Your response to treatment is a biological one, not a psychological one, asserts neurosurgeon Rohan Ramakrishna, M.D. Read more

Marcin Imielinski, M.D., Ph.D., has received $495,000 to investigate a potential class of genetic changes that may be driving cancer. Read more